期刊文献+

血清胱抑素C与25-羟维生素D及同型半胱氨酸在糖尿病肾病患者中的临床应用价值 被引量:25

Clinical application value of serum cystain C,25-hydroxy vitamin D and homocysteine in diabetic nephropathy patients
下载PDF
导出
摘要 目的分析血清胱抑素C、25-羟维生素D[25-(OH)D]、同型半胱氨酸(Hcy)在糖尿病肾病(DN)患者中的临床应用价值。方法选取2018年7月至2020年1月于哈尔滨市第一医院就诊的2型糖尿病并发DN患者90例作为观察组,根据尿白蛋白排泄率水平分为正常蛋白尿组(30例)、早期肾病组(32例)、临床肾病组(28例)3个亚组,另外选取同期在本院健康体检者30例作为对照组。比较各组血清胱抑素C、25-(OH)D、Hcy水平。结果正常蛋白尿组、早期肾病组和临床肾病组血清胱抑素C、Hcy水平均高于对照组[(0.69±0.28)、(0.92±0.31)、(1.37±0.36)mg/L比(0.43±0.25)mg/L,(10.7±3.2)、(13.7±3.8)、(17.0±4.3)μmol/L比(9.1±2.1)μmol/L],25-(OH)D水平均低于对照组[(27.5±2.6)、(22.5±4.8)、(20.6±3.4)μg/L比(35.7±3.6)μg/L],差异均有统计学意义(均P<0.05)。临床肾病组血清胱抑素C、Hcy水平均高于早期肾病组和正常蛋白尿组,25-(OH)D水平低于早期肾病组和正常蛋白尿组;早期肾病组胱抑素C、Hcy水平均高于正常蛋白尿组,25-(OH)D水平低于正常蛋白尿组,差异均有统计学意义(均P<0.05)。结论血清胱抑素C、25-(OH)D及Hcy水平与DN的发病和进展密切相关,监测三者水平有利于及时采取措施阻止或延缓DN发生或发展。 Objective To analyze the clinical application value of serum cystain C,25-hydroxy vitamin D[25-(OH)D]and homocysteine(Hcy)in diabetic nephropathy(DN)patients.Methods From July 2018 to January 2020,90 patients in type 2 diabetes mellitus complicated with DN admitted to the First Hospital of Harbin were selected as the observation group.According to the urinary albumin excretion rate,they were divided into normal proteinuria group(30 cases),early nephropathy group(32 cases)and clinical nephropathy group(28 cases).In addition,30 healthy people in our hospital during the same period were selected as the control group.The levels of cystatin C,25-(OH)D and Hcy were compared among the four groups.Results The levels of cystatin C and Hcy in normal proteinuria group,early nephropathy group and clinical nephropathy group were higher and 25-(OH)D level was lower than those in control group[(0.69±0.28),(0.92±0.31),(1.37±0.36)mg/L vs(0.43±0.25)mg/L;(10.7±3.2),(13.7±3.8),(17.0±4.3)μmol/L vs(9.1±2.1)μmol/L;(27.5±2.6),(22.5±4.8),(20.6±3.4)μg/L vs(35.7±3.6)μg/L],the differences were statistically significant(all P<0.05).The levels of cystatin C and Hcy in clinical nephropathy group were higher and 25-(OH)D level was lower than those in early nephropathy group and normal proteinuria group,and the levels of cystatin C and Hcy in early nephropathy group were higher and 25-(OH)D level was lower than those in normal proteinuria group,and the differences were statistically significant(all P<0.05).Conclusions The serum levels of cystain C,25-(OH)D and Hcy are closely related to the occurrence and progression of DN.Monitoring the three indexes levels is conducive to take timely measures to prevent or delay DN occurrence or development.
作者 王莹 吴东红 程瑶 梁桂敏 马晶 Wang Ying;Wu Donghong;Cheng Yao;Liang Guimin;Ma Jing(The First Ward,Department of Endocrinology,the First Hospital of Harbin,Harbin 150010,China)
出处 《中国医药》 2020年第11期1737-1739,共3页 China Medicine
基金 黑龙江省卫生健康委课题(2018089)。
关键词 2型糖尿病 糖尿病肾病 胱抑素C 25-羟维生素D 同型半胱氨酸 Type 2 diabetes mellitus Diabetic nephropathy Cystain C 25-hydroxy vitamin D Homocysteine
  • 相关文献

参考文献1

二级参考文献25

  • 1Cohen-Bucay A, Viswanathan G. Urinary markers of glomeru- lar injury in diabetic nephropathy[J]. Int J Nephrol, 2012, 2012:146987. 被引量:1
  • 2KIDQI. KDOQI Clinical Practice Guidelines and Clinical Prac- tice Recommendations for Diabetes and Chronic Kidney Disease [ J]. Am J Kidney Dis, 2007,49 (2 Suppl 2) : S12- S154. 被引量:1
  • 3Zoccali C ,Jager KJ. Hyperhomocysteinemia: a renal and cardi- ovascular risk factor? [J]. Nat Rev Nephrol, 2010, 6 (12) : 695-696. 被引量:1
  • 4Lan TH, Xu ZW, Wang Z, et al. Ginsenoside Rbl prevents homocysteine-induced endothelial dysfunction via PI3K/Aktac- tivation and PKC inhibition[J]. Biochem Pharmacol, 2011,82 (2) : 148-155. 被引量:1
  • 5Clio EH,Kim EH,Kim WG,et al. Homocysteine as a risk fac-tor for development of microalbuminuria in type 2 diabetes[J]. Korean Diabetes J, 2010,34 (3) : 200-206. 被引量:1
  • 6Wang H, Cui K, Xu K, et al. Association between plasma bo- mocysteine and progression of early nephropathy in type 2 dia- betic patients[J]. Int J Clin Exp Med, 2015, 8 (7): 11174- 11180. 被引量:1
  • 7Mogensen CE. Mieroalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas[J]. Diabetologia, 1999,42 (3) : 263-285. 被引量:1
  • 8Whiting PF, Westwood ME, Rutjes AW, et al. Evaluation of QUADAS: a tool for the quality assessment of diagnostic accu- racy studies[J]. BMC Med Res Methodol, 2006,6 : 9. 被引量:1
  • 9Zhang L,Wang F,Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet,2012,379 (9818) :815-822. 被引量:1
  • 10张晓坤,曾华,李勰璘,古雅珏,杨晓仪.五项诊断指标联合检测对糖尿病肾病患者应用的价值[J].广州医学院学报,2011,39(1):51-54. 被引量:1

共引文献3

同被引文献321

引证文献25

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部